Alzamend Neuro ALZN
NASDAQ ALZN
$1.79 -0.03 (-1.37%)
As of: Sep 30, 2026 · 2:29 PM EDT

Alzamend Neuro (ALZN) Notes Payables (2024)

Updated

Alzamend Neuro (ALZN) recorded Notes Payables of $300,714 in fiscal Q4 2024 (quarter ended Apr 30, 2024).

Analysis

Alzamend Neuro (ALZN) Notes Payables (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Alzamend Neuro 8.78 Mn 8.78 Mn -
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2024 300,714.00
API Access

Alzamend Neuro Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=ALZN&period=max&api_key=YOUR_API_KEY